Virologisk respons efter 1 års behandling og 6 måneders opfølgning var 36% for genotype 1 og 81% for genotype 2/ 3/ 4.
Virological responses after 1 year of treatment and 6 months of follow-up were 36% for genotype 1 and 81% for genotype 2/ 3/ 4.